Therapeutic compositions of oncomodulin
AssigneeChildren's Medical Center Corporation
InventorsLarry I. Benowitz, Yuqin Yin
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for treating and/or preventing damage to a retina or optic nerve in a subject comprising administering to the subject a therapeutically effective amount of oncomodulin. Preferably, the subject is a mammal, most preferably, a human. In preferred embodiments, the oncomodulin may be used in combination with mannose, a mannose derivative and/or inosine.
Claims6
A pharmaceutical composition comprising oncomodulin, a cAMP modulator, and a pharmaceutically acceptable carrier.
A pharmaceutical composition comprising oncomodulin, an axogenic factor, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.